CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Essential oilsWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (4)


Name (Synonyms) Correlation
drug755 Lopinavir and Ritonavir Tablets Wiki 1.00
drug1351 Tap water Wiki 1.00
drug95 Arbidol Wiki 0.71
drug1060 Povidone-Iodine Wiki 0.58

Correlated MeSH Terms (4)


Name (Synonyms) Correlation
D003141 Communicable Diseases NIH 0.10
D007239 Infection NIH 0.07
D045169 Severe Acute Respiratory Syndrome NIH 0.06
D018352 Coronavirus Infections NIH 0.05

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 A Pilot, Open-Labelled, Randomised Controlled Trial Of Povidone-Iodine Vs Essential Oil And Tap Water Gargling For COVID-19 Patients

The purpose of this study is to assess the ability of regular gargling to eliminate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the throat and nasopharynx. This 4 arms interventional study compares the effect of gargling using povidone-iodine, essential oils- based, tap water with control (no intervention) among Stage 1 coronavirus disease-2019 (COVID-19) patients. Findings from this study will provide new insight into the importance of gargling in the treatment and prevention of COVID-19.

NCT04410159 COVID-19 Drug: Povidone-Iodine Drug: Essential oils Other: Tap water

Primary Outcomes

Description: Swabs from oropharynx and nasopharynx will be taken at day 4 and 6 of intervention.

Measure: Early Viral Clearance

Time: 6 days

Secondary Outcomes

Description: Swabs from oropharynx and nasopharynx will be taken at day 12

Measure: Late viral clearance

Time: 12 days

Description: Progression will be monitored by symptoms diary for 7 days

Measure: Symptoms progression

Time: 7 days

Description: Progression will be monitored by clinical data for 14 days

Measure: Disease Progression

Time: 14 days

Description: Progression will be monitored by laboratory data for 14 days

Measure: Disease Progression 2

Time: 14 days


No related HPO nodes (Using clinical trials)